Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 65162-372

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 65162-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Oxybutynin Chloride Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

FDA Label Image

Study 1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

FDA Label Image

Study 2 (Oxybutynin Chloride Extended Release Tablets Usp 5)

FDA Label Image

Study 3 (Oxybutynin Chloride Extended Release Tablets Usp 6)

FDA Label Image

5mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 7)

This is the product information for an extended-release tablet containing 5 mg of oxybutynin chloride in a controlled-release formulation. The package insert contains dosage information. The tablets should be stored at room temperature and protected from moisture and humidity. This product is only available with a prescription and is distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

10mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 8)

This is a description of a drug called Oxybutynin Chloride in extended-release tablet form, each of which contains 10 milligrams of the drug in a formulation intended to release it slowly over time. The recommended dosage should be found in the package insert. The tablets should be stored at a temperature between 20 and 25 degrees Celsius and be protected from moisture and humidity. The drug is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

FDA Label Image

15mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 9)

NDC 65162-373-03 is a medication called Oxybutynin Chloride Extended-Release Tablets, USP containing 15 mg of oxybutynin chloride in a controlled-release formulation. Dosage information is available in the package insert. It should be stored at room temperature and protected from moisture and humidity. Distributed by Amneal Pharmaceuticals LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.